19-Apr-2024
Inogen Announces Executive VP and CMO Departure Plans
TipRanks (Mon, 15-Apr 4:35 PM ET)
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
Business Wire (Wed, 10-Apr 8:30 AM ET)
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
Business Wire (Mon, 25-Mar 8:30 AM ET)
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Business Wire (Thu, 7-Mar 4:00 PM ET)
Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
Business Wire (Tue, 30-Jan 4:00 PM ET)
Inogen Names Michael Bourque as New Chief Financial Officer
Business Wire (Wed, 24-Jan 4:00 PM ET)
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
Inogen trades on the NASDAQ stock market under the symbol INGN.
As of April 19, 2024, INGN stock price declined to $6.75 with 255,783 million shares trading.
INGN has a beta of 1.55, meaning it tends to be more sensitive to market movements. INGN has a correlation of 0.06 to the broad based SPY ETF.
INGN has a market cap of $157.33 million. This is considered a Micro Cap stock.
Last quarter Inogen reported $76 million in Revenue and -$.83 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.21.
In the last 3 years, INGN stock traded as high as $82.35 and as low as $4.13.
The top ETF exchange traded funds that INGN belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
INGN stock has underperformed the market in the last year with a return of -48.1%, while SPY returned +21.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in INGN shares. However, INGN has outperformed the market in the last 3 month and 2 week periods, returning +26.2% and +7.1%, while SPY returned +3.0% and -4.5%, respectively. This indicates INGN has been having a stronger performance recently.
INGN support price is $6.76 and resistance is $7.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INGN stock will trade within this expected range on the day.